Enhancing the Trustworthiness of the Endocrine Society's Clinical Practice Guidelines.

Select Content Type
Clinical Guidelines
Authored By
McCartney CR, Corrigan MD, Drake MT, El-Hajj Fuleihan G, Korytkowski MT, Lash RW, Lieb DC, McCall AL, Muniyappa R, Piggott T, Santesso N, Schünemann HJ, Wiercioch W, McDonnell ME, Murad MH
Authored On
Interests
Endocrinology
Internal/Family Medicine
Speciality
Endocrinology
Internal/Family Medicine
Book Detail
volume
107
ISSN
1945-7197
Publication Date
Actions
Download in App
Event Data
{"article_title":"Enhancing the Trustworthiness of the Endocrine Society's Clinical Practice Guidelines.","author":"McCartney CR, Corrigan MD, Drake MT, El-Hajj Fuleihan G, Korytkowski MT, Lash RW, Lieb DC, McCall AL, Muniyappa R, Piggott T, Santesso N, Sch\ufffdnemann HJ, Wiercioch W, McDonnell ME, Murad MH","journal_title":"The Journal of clinical endocrinology and metabolism","issn":"1945-7197","isbn":"","publication_date":"2022 Jul 14","volume":"107","issue":"8","first_page":"2129","page_count":"","accession_number":"35690966","doi":"10.1210\/clinem\/dgac290","publisher":"Oxford University Press","doctype":"Journal Article","subjects":"Evidence-Based Medicine methods; Humans","interest_area":["Endocrinology"," Internal\/Family Medicine"],"abstract":"In an effort to enhance the trustworthiness of its clinical practice guidelines, the Endocrine Society has recently adopted new policies and more rigorous methodologies for its guideline program. In this Clinical Practice Guideline Communication, we describe these recent enhancements-many of which reflect greater adherence to the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach to guideline development-in addition to the rationale for such changes. Improvements to the Society's guideline development practices include, but are not limited to, enhanced inclusion of nonendocrinologist experts, including patient representatives, on guideline development panels; implementation of a more rigorous conflict\/duality of interest policy; a requirement that all formal recommendations must be demonstrably underpinned by systematic evidence review; the explicit use of GRADE Evidence-to-Decision frameworks; greater use and explanation of standardized guideline language; and a more intentional approach to guideline updating. Lastly, we describe some of the experiential differences our guideline readers are most likely to notice. \ufffd The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=35690966&authtype=shib&custid=ns346513","isPdfLink":true,"isSAML":false,"additionalInfo":{"Authored_By":"McCartney CR, Corrigan MD, Drake MT, El-Hajj Fuleihan G, Korytkowski MT, Lash RW, Lieb DC, McCall AL, Muniyappa R, Piggott T, Santesso N, Sch\u00fcnemann HJ, Wiercioch W, McDonnell ME, Murad MH","Journal_Info":"Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE","Publication_Type":"Journal Article; Research Support, Non-U.S. Gov't","Published_Date":"2022-07-14","Source":"The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2022 Jul 14; Vol. 107 (8), pp. 2129-2138.","Languages":"English","Electronic_ISSN":"1945-7197","MeSH_Terms":"Evidence-Based Medicine*\/methods, Humans","Subjects":"Humans, Evidence-Based Medicine methods","Title_Abbreviations":"The Journal of clinical endocrinology and metabolism","Volume":"107"},"header":{"DbId":"mdl","DbLabel":"MEDLINE Ultimate","An":"35690966","RelevancyScore":"883","PubType":"Academic Journal","PubTypeId":"academicJournal","PreciseRelevancyScore":"882.739196777344"},"plink":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=35690966&authtype=shib&custid=ns346513&group=main&profile=eds","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=35690966&authtype=shib&custid=ns346513&group=main&profile=eds"}
ISSN
1945-7197
IS_Ebsco
true
Upload Link
https://search.ebscohost.com/login.aspx?direct=true&db=mdl&AN=35690966&authtype=shib&custid=ns346513
Additional Info
["McCartney CR, Corrigan MD, Drake MT, El-Hajj Fuleihan G, Korytkowski MT, Lash RW, Lieb DC, McCall AL, Muniyappa R, Piggott T, Santesso N, Sch\u00fcnemann HJ, Wiercioch W, McDonnell ME, Murad MH","Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE","Journal Article; Research Support, Non-U.S. Gov't","2022-07-14","The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2022 Jul 14; Vol. 107 (8), pp. 2129-2138.","English","1945-7197","Evidence-Based Medicine*\/methods, Humans","Humans, Evidence-Based Medicine methods","The Journal of clinical endocrinology and metabolism","107"]
Description
In an effort to enhance the trustworthiness of its clinical practice guidelines, the Endocrine Society has recently adopted new policies and more rigorous methodologies for its guideline program. In this Clinical Practice Guideline Communication, we describe these recent enhancements-many of which reflect greater adherence to the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach to guideline development-in addition to the rationale for such changes. Improvements to the Society's guideline development practices include, but are not limited to, enhanced inclusion of nonendocrinologist experts, including patient representatives, on guideline development panels; implementation of a more rigorous conflict/duality of interest policy; a requirement that all formal recommendations must be demonstrably underpinned by systematic evidence review; the explicit use of GRADE Evidence-to-Decision frameworks; greater use and explanation of standardized guideline language; and a more intentional approach to guideline updating. Lastly, we describe some of the experiential differences our guideline readers are most likely to notice.<br /> (© The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
Published Date